Picture of Biogaia AB logo

BIOG B Biogaia AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-8.83%
3m+2.97%
6m+5.97%
1yr+17.09%
Volume Change (%)
10d/3m+33.22%
Price vs... (%)
52w High-14.53%
50d MA-6.33%
200d MA+7.19%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)28.36
PEG Ratio (f)3.32
EPS Growth (f)9.34%
Dividend Yield (f)1.77%
Valuation (ttm)IndustryMarket
Price to Book Value5.76
Price to Tang. Book6.43
Price to Free Cashflow31.01
Price to Sales9.03
EV to EBITDA21.69

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital20.73%
Return on Equity18.26%
Operating Margin34.18%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueSEKm768.35747.08785.111,103.961,296.511,404.51,56911.81%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-12.82-6.82+3.1+80.22-2.56+8.74+10.72n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Biogaia AB EPS forecast chart

Profile Summary

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
January 2nd, 1990
Public Since
January 1st, 1998
No. of Shareholders
10,908
No. of Employees
210
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
100,982,310

BIOG B Share Price Performance

Upcoming Events for BIOG B

Q1 2024 Biogaia AB Interim Management Release

Biogaia AB Annual Shareholders Meeting

Dividend For BIOGb.ST - 1.9000 SEK

Dividend For BIOGb.ST - 5.0000 SEK

Q2 2024 Biogaia AB Earnings Release

Similar to BIOG B

Picture of BoneSupport Holding AB logo

BoneSupport Holding AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Calliditas Therapeutics AB logo

Calliditas Therapeutics AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Camurus AB logo

Camurus AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Cline Scientific AB logo

Cline Scientific AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Corline Biomedical AB logo

Corline Biomedical AB

se flag iconOMX Nordic Exchange Stockholm

FAQ